Broker Recommendations Surgery Partners, Inc.

Stocks

SGRY

US86881A1007

Healthcare Facilities & Services

Market Closed - Nasdaq Other stock markets 21:00:00 20/07/2026 BST			5-day change	1st Jan Change
16.03 ^USD	+0.25%		+0.31%	+3.75%

05-13	Surgery Partners Delivered Solid Q1 Beat Amid Stabilizing Portfolio, RBC Says	MT
05-05	Tranche Update on Surgery Partners, Inc.'s Equity Buyback Plan announced on March 2, 2026.	CI

Broker Recommendations

03-05	UBS Adjusts Price Target on Surgery Partners to $21 From $29, Maintains Buy Rating	MT
03-04	RBC Cuts Price Target on Surgery Partners to $20 From $31, Keeps Outperform Rating	MT
11-13	UBS Adjusts Surgery Partners Price Target to $29 From $34, Maintains Buy Rating	MT
11-11	Surgery Partners Tracking Toward Midpoint of 2025 Same-Store Revenue Growth, RBC Says	MT
11-11	RBC Cuts Price Target on Surgery Partners to $31 From $35, Keeps Outperform Rating	MT
11/03/25	Macquarie Trims Price Target on Surgery Partners to $33 From $34, Keeps Outperform Rating	MT
04/03/25	UBS Cuts Price Target on Surgery Partners to $34 From $38, Keeps Buy Rating	MT
03/12/24	JPMorgan Adjusts Surgery Partners Price Target to $28 From $38, Maintains Neutral Rating	MT
20/11/24	RBC Cuts Price Target on Surgery Partners to $35 From $49, Keeps Outperform Rating	MT
13/11/24	Macquarie Adjusts Surgery Partners Price Target to $34 From $35, Maintains Outperform Rating	MT
14/10/24	Surgery Partners Benefits From Growth Outlook for Outpatient Centers, UBS Says	MT
14/10/24	UBS Initiates Surgery Partners at Buy With $38 Price Target	MT
11/10/24	KeyBanc Initiates Surgery Partners at Sector Weight	MT
28/06/24	Macquarie Initiates Surgery Partners at Outperform With $31 Price Target	MT
24/01/24	RBC Raises Price Target on Surgery Partners to $49 From $47, Keeps Outperform Rating	MT
14/11/23	TD Cowen Upgrades Surgery Partners to Outperform From Market Perform, Cuts Price Target to $35 From $39	MT
02/08/23	Barclays Adjusts Price Target on Surgery Partners to $51 From $56, Maintains Overweight Rating	MT
11/07/23	Mizuho Adjusts Price Target on Surgery Partners to $50 From $48, Maintains Buy Rating	MT
02/06/23	BofA Securities Upgrades Surgery Partners to Buy From Neutral, Adjusts Price Target to $45 From $42	MT
12/05/23	Mizuho Starts Surgery Partners at Buy With $48 Price Target	MT
02/05/23	Citigroup Adjusts Price Target on Surgery Partners to $47 From $40, Maintains Buy Rating	MT
21/04/23	Cantor Fitzgerald Initiates Surgery Partners at Overweight With $43 Price Target	MT
03/03/23	RBC Trims Price Target on Surgery Partners to $47 From $48, Maintains Outperform Rating	MT
18/01/23	Barclays Adjusts Price Target on Surgery Partners to $56 From $69, Maintains Overweight Rating	MT
05/12/22	Benchmark Adjusts Price Target on Surgery Partners to $47 From $60, Maintains Buy Rating	MT